Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease

JAMA Neurology Author Interviews
31/10/2022 19 min
Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease

Listen "Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease"

Descargar episodio Ver en sitio original

Episode Synopsis

Interview with Camille Carroll, MD, PhD, author of Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease: A Randomized Clinical Trial. Hosted by Cynthia E. Armand, MD. Related Content: Evaluation of Simvastatin as a Disease-Modifying Treatment for Patients With Parkinson Disease

More episodes of the podcast JAMA Neurology Author Interviews

Hemorrhage and Risk Factors in Unruptured Brain AVM 06/10/2025
Intravenous Argatroban or Eptifibatide and Mechanical Thrombectomy 18/08/2025
GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension 14/07/2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome 02/06/2025
Fremanezumab for the Treatment of Migraine and Major Depressive Disorder 05/05/2025
Optimal Delay Time to Initiate Anticoagulation After AF-Associated Ischemic Stroke 31/03/2025
Location and Timing of Recurrent, Nontraumatic Intracerebral Hemorrhage 03/03/2025
Cardiovascular Safety of Anti-CGRP Monoclonal Antibodies in Older Adults or Adults With Disability With Migraine 06/01/2025
β-Blocker Use and Delayed Onset and Progression of Huntington Disease 02/12/2024
Alzheimer Disease as a Clinical-Biological Construct 01/11/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA